ArticleCancers2022

Comprehensive Pan-Cancer Analyses of Immunogenic Cell Death as a Biomarker in Predicting Prognosis and Therapeutic Response.

Yuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.